{"id":"NCT00855166","sponsor":"AstraZeneca","briefTitle":"Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes","officialTitle":"A 24-week,Multi-centre,Int.,Double-blind,Rand.,Parallel-group,Plac.-Controlled,Phase III Study With a 78-week Ext.Per. to Evaluate the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2010-06","completion":"2011-12","firstPosted":"2009-03-04","resultsPosted":"2013-10-14","lastUpdate":"2013-10-14"},"enrollment":182,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Dapagliflozin","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Sitagliptin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being carried out to see if dapagliflozin in addition to metformin decreases body weight and if so, how it compares with metformin alone.","primaryOutcome":{"measure":"Adjusted Mean Change in Total Body Weight","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Placebo Plus Metformin","deltaMin":-0.88,"sd":0.2746},{"arm":"Dapagliflozin Plus Metformin","deltaMin":-2.96,"sd":0.2766}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":21,"countries":["Bulgaria","Czechia","Hungary","Poland","Sweden"]},"refs":{"pmids":["38770818","26894924","23906445","22651373"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":91},"commonTop":["Nasopharyngitis","Arthralgia"]}}